DEC 08, 2021 9:00 AM PST

The MAD7™ nuclease in plant editing: overcoming CRISPR bottlenecks with MAD TiGER

Sponsored by: Inscripta
C.E. Credits: P.A.C.E. CE Florida CE
Speakers

Abstract
Date:  December 8, 2021
Time: 9:00am (PST),  12:00am (EST)
 
CRISPR editing has revolutionized plant breeding, and the MAD7 CRISPR nuclease developed by InscriptaTM is democratizing access to CRISPR technologies. Hudson River Biotechnology has developed a proprietary, validated molecular breeding workflow called MAD TiGER, which stands for Target identification, Guide selection, Entry into the cell and Regeneration using the MAD7 nuclease. MAD TiGER enables molecular breeding in an end-to-end fashion, providing innovative solutions to the typical barriers encountered in CRISPR plant breeding projects, such as cell entry and regeneration. The MAD TiGER workflow uses the MAD7 nuclease, nanotechnology and various synthetic gels to enable faster onset of cell divisions in regenerating and de-differentiating protoplasts towards micro-calli formation. During this webinar, Gabino Sanchez of Hudson River Biotechnology will provide an overview of the MAD TiGER workflow and discuss examples of using an integrated workflow for molecular breeding. You will also learn more about the MAD7 nuclease from Inscripta.
 
Learning Objectives
  • Describe the current workflows for CRISPR-enabled plant breeding
  • Recognize the technical barriers encountered in CRISPR breeding projects
  • Demonstrate successful examples and the benefits of using integrated, technology-based workflow for molecular breeding
  • Understand the commercial licensing options for MAD7 editing technologies
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
NOV 09, 2021 11:00 AM PST
C.E. CREDITS
NOV 09, 2021 11:00 AM PST
Date: November 09, 2021 Time: 11:00am (PDT), 02:00pm (EDT) Clinical translation of human pluripotent stem cells (hPSCs) requires advanced strategies that ensure safe and robust long-term gro...
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
OCT 27, 2021 6:00 AM PDT
C.E. CREDITS
OCT 27, 2021 6:00 AM PDT
Date: October 27, 2021 Time: 6:00 AM PDT, 9:00 AM EDT Etanercept is a recombinant Fc fusion protein therapeutic that has a complex distribution of post-translation modifications (PTM), such...
AUG 24, 2021 11:00 AM PDT
C.E. CREDITS
AUG 24, 2021 11:00 AM PDT
Date: August 24, 2021 Time: 11:00am (PDT), 1:00pm (EDT) Electron-based dissociation mechanisms have shown great promise for advanced characterization of biomolecules. However, routine adopti...
Loading Comments...
Show Resources
Event Countdown
  • 0 Days
  • 0 Hours
  • 0 Minutes
  • 0 Seconds